Disposition of 3256 shares by Smith Ian F of Solid Biosciences subject to Rule 16b-3
SLDB Stock | USD 4.14 0.24 6.15% |
About 55% of Solid Biosciences' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Solid Biosciences LLC suggests that some traders are interested. The current market sentiment, together with Solid Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Solid Biosciences LLC stock news signals to limit their universe of possible portfolio assets.
Solid |
Filed transaction by Solid Biosciences LLC Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Solid Biosciences Fundamental Analysis
We analyze Solid Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Solid Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Solid Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Solid Biosciences is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Solid Biosciences LLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Solid Biosciences stock to make a market-neutral strategy. Peer analysis of Solid Biosciences could also be used in its relative valuation, which is a method of valuing Solid Biosciences by comparing valuation metrics with similar companies.
Peers
Solid Biosciences Related Equities
PASG | Passage Bio | 45.61 | ||||
ACRV | Acrivon Therapeutics, | 16.34 | ||||
ALEC | Alector | 8.99 | ||||
CCCC | C4 Therapeutics | 7.10 | ||||
IPSC | Century Therapeutics | 6.73 | ||||
ANEB | Anebulo Pharmaceuticals | 4.43 | ||||
LRMR | Larimar Therapeutics | 4.24 | ||||
MLYS | Mineralys Therapeutics, | 4.08 | ||||
CABA | Cabaletta Bio | 3.00 | ||||
BDTX | Black Diamond | 2.80 | ||||
EWTX | Edgewise Therapeutics | 2.55 | ||||
MOLN | Molecular Partners | 2.53 | ||||
CGEM | Cullinan Oncology | 2.34 | ||||
STOK | Stoke Therapeutics | 1.95 | ||||
PMVP | Pmv Pharmaceuticals | 1.31 | ||||
GLUE | Monte Rosa | 0.84 | ||||
RVMD | Revolution Medicines | 0.27 |
Complementary Tools for Solid Stock analysis
When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |